The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apatinib combined with ifosfamide and etoposide versus ifosfamide and etoposide in relapsed or refractory osteosarcoma (OAIE/PKUPH-sarcoma 11): A multicenter, randomized controlled trial.
 
Lu Xie
No Relationships to Disclose
 
Jie Xu
No Relationships to Disclose
 
Xin Sun
No Relationships to Disclose
 
Xin Liang
No Relationships to Disclose
 
Kuisheng Liu
No Relationships to Disclose
 
Kunkun Sun
No Relationships to Disclose
 
Yuan Li
No Relationships to Disclose
 
Rong Liu
No Relationships to Disclose
 
Du Wang
Employment - Jiangsu Hengrui Pharmaceuticals Co, Ltd.
 
Shurong Shao
Employment - Jiangsu Hengrui Pharmaceuticals Co, Ltd.
 
Peiyu Li
Employment - Jiangsu Hengrui Pharmaceuticals Co, Ltd.
 
Zheng Pang
Employment - Jiangsu Hengrui Pharmaceuticals Co, Ltd.
 
Guangxin Zhou
No Relationships to Disclose
 
Sujia Wu
No Relationships to Disclose
 
Yingqi Hua
No Relationships to Disclose
 
Haiyan Hu
No Relationships to Disclose
 
Yi Yang
No Relationships to Disclose
 
Tao Ji
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Xiaodong Tang
No Relationships to Disclose